Cargando…
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
To understand SARS-CoV-2 immunity after natural infection or vaccination, functional assays such as virus neutralising assays are needed. So far, assays to detect SARS-CoV-2 neutralising antibodies rely on cell-culture based infection assays either using wild type SARS-CoV-2 or pseudotyped viruses....
Autores principales: | Meyer, Benjamin, Reimerink, Johan, Torriani, Giulia, Brouwer, Fion, Godeke, Gert-Jan, Yerly, Sabine, Hoogerwerf, Marieke, Vuilleumier, Nicolas, Kaiser, Laurent, Eckerle, Isabella, Reusken, Chantal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605318/ https://www.ncbi.nlm.nih.gov/pubmed/33043818 http://dx.doi.org/10.1080/22221751.2020.1835448 |
Ejemplares similares
-
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
por: Winichakoon, Poramed, et al.
Publicado: (2023) -
Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination()
por: Pezzati, Laura, et al.
Publicado: (2023) -
Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA
por: Tuells, José, et al.
Publicado: (2022) -
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay
por: Fogolari, Marta, et al.
Publicado: (2023) -
SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame
por: Han, Wanda G. H., et al.
Publicado: (2022)